Bone Marrow Lesions: Etiology and Pathogenesis at the Hip
Overview
Affiliations
Bone marrow lesions (BML) are painful changes in subchondral bone which can be reliably identified on magnetic resonance imaging and have been identified in patients suffering from hip osteoarthritis (OA) and related conditions. Created via repetitive microdamage at the articular surface and dysregulated subchondral healing, BML have been linked to traumatic, inflammatory, degenerative, metabolic and neoplastic processes. While BML are known to be a common pathology throughout the body, BML at the hip have not been extensively studied in comparison to those at the knee. Due to the hip's unique biomechanical architecture, function and loading, and independent risk factors leading to hip OA, hip BMLs must be independently understood. The identification of BML in the setting of a pre-osteoarthritic condition may provide a target for treatment and prevention of joint degeneration. By continuing to define and refine the relationships between BML, subchondral bone cysts and OA, prevention, diagnosis and treatment of OA could shift, leading to an improved quality of life and increased longevity of individuals' native hips.
Bone marrow lesions in osteoarthritis: biomarker or treatment target? A narrative review.
Ge L, Zhang X, Zhu R, Cai G Skeletal Radiol. 2024; 54(2):175-191.
PMID: 38877110 DOI: 10.1007/s00256-024-04725-0.
Bone marrow lesions in osteoarthritis: From basic science to clinical implications.
Shi X, Mai Y, Fang X, Wang Z, Xue S, Chen H Bone Rep. 2023; 18:101667.
PMID: 36909666 PMC: 9996250. DOI: 10.1016/j.bonr.2023.101667.
Wang B, Liang K, Chen C, Wang C Diagnostics (Basel). 2023; 13(1).
PMID: 36611426 PMC: 9818587. DOI: 10.3390/diagnostics13010134.
Mesenchymal stem cells for subchondral bone marrow lesions: From bench to bedside.
Pasculli R, Kenyon C, Berrigan W, Mautner K, Hammond K, Jayaram P Bone Rep. 2022; 17:101630.
PMID: 36310763 PMC: 9615138. DOI: 10.1016/j.bonr.2022.101630.